Belgian Journal of Paediatrics
Outcome of Febrile Infants ≤3 Months of Age Admitted to the Emergency Department of a Belgian Tertiary Pediatric Hospital
PDF

Keywords

febrile infant
fever without source
serious bacterial infection
viral infection
emergency department

Categories

How to Cite

Bouharmont, C., Maure, A., Vandescuren, I., Godefroid, N., Ranguelov, N., Hermans, D., Goubau, C., Berardis, S., Malek Abrahimians , E., Van der Linden, D., Chatzis, O., & Lysy, P. (2024). Outcome of Febrile Infants ≤3 Months of Age Admitted to the Emergency Department of a Belgian Tertiary Pediatric Hospital. Belgian Journal of Paediatrics, 26(2), 131–135. Retrieved from https://belgjpaediatrics.com/index.php/bjp/article/view/260

Abstract

Background: Fever in infants less than 3 months old is a common reason for pediatric emergency department visits, most children presenting fever without source, and they often undergo several medical examinations to exclude a bacterial infection (BI), frequently requiring hospitalization. This study sought to document fever outcomes in newborns and infants under 3 months old, based on hospitalization data, to find a prediction rule enabling healthcare professionals to identify febrile infants at risk for BI.

Methods: We conducted a single-center retrospective study covering a period from January 2016 to December 2022. Overall, 150 infants aged up to 3 months old were admitted for fever without source at Cliniques universitaires Saint-Luc emergency department, Brussels, Belgium. We analyzed the patient’s medical history, clinical presentation, and complementary test results to identify predictors of BI.

Results: Among test results, we noted a significant increase in C-reactive protein levels (CRP=12.8mg/L in BI cases; 5.5mg/L in viral infection cases, p-value=0.04) and neutrophil numbers in BI cases in children under 4 weeks old. No anamnestic or clinical factors could effectively differentiate febrile children aged less than 3 months at risk of developing BI.

Conclusion: Further investigations are required to identify infants at risk for BI using new biological parameters, including procalcitonin dosage. The management protocol of these children must be re-evaluated to assess the complementary tests to be performed, whether hospitalization would be required and, if so, which patients are eligible for hospital admission.

PDF